why choose us

First received: November 29, 2024

Clinical Trial: A Research Study to Compare Blood Levels of Cagrilintide and Semaglutide After Single Doses of Different Versions of Injectable CagriSema in Adults With Overweight or Obesity

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Obesity

Study Type: INTERVENTIONAL


Official Title: Comparing the Pharmacokinetics of Cagrilintide and Semaglutide Following Single Subcutaneous Doses of Different CagriSema Presentations, in a Crossover Manner in Adult Participants With Overweight or

Brief Summary: This study will compare the blood levels of cagrilintide and semaglutide when the same dose is given in two different versions of CagriSema.CagriSema is a medicine that combines two medicines called cagrilintide and semaglutide.It is still being tested in studies and is not yet available for doctors to prescribe.Participants will get an injection with each of the two versions of CagriSema at two different times at the clinic.Like all medicines, the study medicine may have side effects.The study will last for about…

Read more